端侧躯体神经至自主神经移植恢复根治性前列腺切除术后勃起功能并改善生活质量
回顾性单中心研究纳入17例根治性前列腺切除术后勃起功能障碍男性,于2015年3月至2017年10月在澳大利亚墨尔本接受双侧股神经选择性束支切断至阴茎海绵体端侧神经移植。术后12个月71%(95%CI 44-90%)恢复足以满意性交的勃起功能,94%(95%CI 71-99%)性功能临床显著改善,82%(95%CI 57-96%)困扰减少。作者建议多中心实施并收集数据确认疗效与可行性。
要点
- 术后12个月71%(95%CI 44-90%)患者恢复足以满意性交的勃起功能。
- 94%(95%CI 71-99%)性功能临床显著改善,82%(95%CI 57-96%)困扰减少。
- 作者建议多中心实施术后神经移植并收集数据确认疗效与可行性。
核心结论
- 端侧神经移植使71%的根治性前列腺切除术后勃起功能障碍男性恢复勃起功能,支持既往发现。
- 94%的男性性生活质量有临床相关改善。
- 作者建议将术后神经移植多中心应用于临床实践,并适当收集数据以确认其疗效与可行性。
研究设计与样本
- 回顾性单中心神经移植经验分析,纳入2015年3月至2017年10月在澳大利亚墨尔本接受手术且符合纳入排除标准的17例根治性前列腺切除术后勃起功能障碍男性。
- 干预为双侧股神经选择性束支切断至阴茎海绵体的显微外科端侧神经移植。
- 采用国际勃起功能指数(IIEF-5)和扩大前列腺癌指数综合量表(EPIC-26)性功能域连续测量结果。
主要发现
- 所有患者根治性前列腺切除术后均有勃起功能障碍。
- 神经移植时中位年龄64岁(四分位距60-66岁)。
- 神经保留与非神经保留根治性前列腺切除至神经移植的中位时间分别为2.4年(四分位距2.1-3.1年)和2.2年(四分位距1.7-5.1年)。
- 中位随访18个月(四分位距15-24个月)。
- 神经移植后12个月,71%(95%CI 44-90%)患者恢复足以满意性交的勃起功能,94%(95%CI 71-99%)性功能临床显著改善,82%(95%CI 57-96%)困扰减少,另有两例轻微伤口感染。
临床怎么用
- 作者建议将根治性前列腺切除术后神经移植多中心应用于临床实践,并适当收集数据以确认其疗效与可行性。
局限性
- 局限性包括回顾性研究设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Radical prostatectomy (RP) is recommended for the treatment of men with clinically localised prostate cancer. However, RP is associated with a high incidence of erectile dysfunction (ED), which can impact the quality of life (QoL) significantly. OBJECTIVE: To evaluate the effectiveness of end-to-side nerve grafting surgery to restore erectile function and improve sexual QoL in men with ED after RP. DESIGN, SETTING, AND PARTICIPANTS: A retrospective review of a single-centre experience of nerve grafting in men with ED following RP was performed. Seventeen men had surgery between March 2015 and October 2017 in Melbourne, Australia, which fulfilled study inclusion and exclusion criteria. INTERVENTION: Microsurgical bilateral end-to-side nerve grafts from a selective fascicular neurotomy of the femoral nerve to the penile corpora cavernosa. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Results were serially measured utilising the International Index of Erectile Function (IIEF-5) and the sexual domain of Expanded Prostate Cancer Index Composite (EPIC-26). The proportion and 95% confidence interval (CI) of men recovering sexual function following nerve grafting were determined. RESULTS AND LIMITATIONS: All patients had ED following their RP. Median age at nerve grafting was 64yr (interquartile range [IQR] 60-66yr). Median time between nerve- and non-nerve-sparing RP, and nerve grafting was 2.4 (IQR 2.1-3.1) and 2.2 (IQR 1.7-5.1)yr, respectively. Median follow-up was 18 (IQR 15-24) mo. At 12mo after nerve grafting, 71% (95% CI 44-90%) of patients had erectile function recovery sufficient for satisfactory sexual intercourse, and 94% (95% CI 71-99%) and 82% (95% CI 57-96%) had clinically significant improvements in sexual function and reduced bother, respectively. There were two minor wound infections. Limitations include the retrospective study design. CONCLUSIONS: End-to-side nerve grafting restored erectile function in 71% of men with ED following RP, supporting previous findings. Of the men, 94% had clinically relevant improvements in sexual QoL. We recommend multicentre implementation of post-RP nerve grafting into clinical practice with appropriate data collection to confirm its efficacy and feasibility. PATIENT SUMMARY: We provide confirmatory evidence that end-to-side nerve grafting surgery restored erectile function and improved sexual quality of life in, respectively, 71% and 94% of men with erectile dysfunction following radical prostatectomy.
引用
- Reece JC, Dangerfield DC, Coombs CJ, et al. End-to-side Somatic-to-autonomic Nerve Grafting to Restore Erectile Function and Improve Quality of Life After Radical Prostatectomy. Eur Urol. 2019. PMID: 30955973. doi:10.1016/j.eururo.2019.03.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。